A group of researchers, including oncologists and data scientists, from the University of Florida and Indiana University hypothesized that GLP-1s hold promise in oncology due to their ability to lower glucose, adiposity, insulin resistance, and systemic inflammation factors associated with cancer progression, according to a July 2025 paper published in JAMA
However, some patients who started these treatments hoping for a new lease on life found themselves facing a different, debilitating battle: severe gastrointestinal complications, including a condition known as gastroparesis, or stomach paralysis. What Are GLP-1 Receptor Agonists
SlimPure UK transformation photo These images do not come from real patients
By 48-72 hours after your early injection, drug levels settle into the same range as they would have been with regular timing